NCT07050498

Brief Summary

The objective of this study is to determine to what extent the use of a software application prior to refractive surgery involving multisensory immersion (visual and auditory) in a hypnotic and relaxing sound and visual environment can reduce anxiety levels. The assessment of preoperative anxiety levels will be based on the administration of a psychometric scale (APAIS scale) and the measurement of salivary cortisol, which is a sensitive marker of the patient's stress level.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress82%
Sep 2024Sep 2026

Study Start

First participant enrolled

September 18, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2025

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 3, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2026

Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

2 years

First QC Date

June 4, 2025

Last Update Submit

June 24, 2025

Conditions

Keywords

refractive surgery

Outcome Measures

Primary Outcomes (1)

  • Preoperative anxiety level

    The preoperative anxiety level is measured on the APAIS scale. The APAIS scale is a self-assessment consisting of six questions with expected responses rated from 1 (the patient strongly disagrees with the statement) to 5 (the patient strongly agrees with the statement) out of a minimum overall score of 6 and a maximum overall score of 30. The first three questions relate to anesthesia, and the next three relate to surgery. Of the three questions (related to anesthesia or surgery), two assess preoperative anxiety, and the third assesses the need for information. The APAIS scale calculates four scores: overall anxiety, surgery-related anxiety, anesthesia-related anxiety, and information need. A total anxiety score of 11 or higher corresponds to a high level of anxiety.

    Preoperative procedure

Secondary Outcomes (14)

  • Intraoperative pain intensity

    Immediately after surgery

  • Postoperative pain intensity

    15 minutes after the End of surgery

  • Intraoperative comfort

    15 minutes after the End surgery

  • Postoperative Overall Patient Satisfaction

    15 minutes after the End of surgery

  • Change in salivary cortisol

    Before any study procedure

  • +9 more secondary outcomes

Study Arms (2)

Virtual reality

EXPERIMENTAL

Preoperative conditioning by virtual reality + Routine preoperative procedure (local anesthesia)

Device: Virtual reality

Usual care

ACTIVE COMPARATOR

Routine preoperative procedure (local anesthesia)

Procedure: Usual Care Group

Interventions

Virtual reality hypnosis software applications are Class I medical devices according to Rule 12 of Directive 93/42/EC. They allow, through a virtual reality headset and headphones, to immerse the patient in a hypnotic sound and visual environment. Several visual scenarios can be proposed, allowing the patient to virtually travel to a beach, the seabed, on an alpine walk, etc.). The HypnoVR Biofeedback virtual reality device is provided by the HypnoVR company.

Virtual reality

Routine preoperative procedure (local anesthesia)

Usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient aged 18 years or older,
  • Patient who has read and signed the consent form for participation in the study after a reflection period (between 10 and 45 minutes)
  • Patient who is a candidate for refractive surgery

You may not qualify if:

  • Contraindication to virtual reality (uncontrolled epilepsy, hearing impairment)
  • Pregnant or breastfeeding patient
  • Cushing's disease, Addison's disease, hypo- or hyperthyroidism
  • Patient treated with topical or systemic corticosteroids
  • Patient treated with neuroleptics, anxiolytics, or antidepressants
  • Patient under legal protection, guardianship, or curatorship
  • Patient participating in another blinded research study
  • Patient not affiliated with the French social security system
  • Patient unable to understand the information provided and/or give written informed consent: dementia, psychosis, impaired consciousness, non-French-speaking patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Monticelli

Marseille, 13008, France

RECRUITING

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single-center, prospective, randomized, open-label study on two parallel groups of patients
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2025

First Posted

July 3, 2025

Study Start

September 18, 2024

Primary Completion (Estimated)

September 18, 2026

Study Completion (Estimated)

September 18, 2026

Last Updated

July 3, 2025

Record last verified: 2025-06

Locations